ArticleCytotechnology2018

MiR-221/222 promote chemoresistance to cisplatin in ovarian cancer cells by targeting PTEN/PI3K/AKT signaling pathway.

Zeinab Amini-Farsani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.